BAF60 A, B, and Cs of muscle determination and renewal

Pier Lorenzo Puri, Mark Mercola

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Developmental biologists have defined many of the diffusible and transcription factors that control muscle differentiation, yet we still have only rudimentary knowledge of the mechanisms that dictate whether a myogenic progenitor cell forms muscle versus alternate lineages, including those that can be pathological in a state of disease or degeneration. Clues about the molecular basis for lineage determination in muscle progenitors are only now emerging from studies of chromatin modifications that avail myogenic genes for transcription, together with analysis of the composition and activities of the chromatin-modifying complexes themselves. Here we review recent progress on muscle determination and explore a unifying theme that environmental cues from the stem or progenitor niche control the selection of specific subunit variants of the switch/sucrose nonfermentable (SWI/SNF) chromatin-modifying complex, creating a combinatorial code that dictates whether cells adopt myogenic versus nonmyogenic cell fates. A key component of the code appears to be the mutually exclusive usage of the a, b, and c variants of the 60-kD structural subunit BAF60 (BRG1/BRM-associated factor 60), of which BAF60c is essential to activate both skeletal and cardiac muscle programs. Since chromatin remodeling governs myogenic fate, the combinatorial assembly of the SWI/SNF complex might be targeted to develop drugs aimed at the therapeutic reduction of compensatory fibrosis and fatty deposition in chronic muscular disorders.

Original languageEnglish
Pages (from-to)2673-2683
Number of pages11
JournalGenes and Development
Volume26
Issue number24
DOIs
Publication statusPublished - 2012

Fingerprint

Chromatin
Muscles
Sucrose
Chromatin Assembly and Disassembly
Cues
Myocardium
Skeletal Muscle
Fibrosis
Transcription Factors
Stem Cells
Pharmaceutical Preparations
Genes
Therapeutics

Keywords

  • Cardiomyocyte
  • Fibrosis
  • Satellite cell
  • Smarcd3
  • TGF β

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

BAF60 A, B, and Cs of muscle determination and renewal. / Puri, Pier Lorenzo; Mercola, Mark.

In: Genes and Development, Vol. 26, No. 24, 2012, p. 2673-2683.

Research output: Contribution to journalArticle

Puri, Pier Lorenzo ; Mercola, Mark. / BAF60 A, B, and Cs of muscle determination and renewal. In: Genes and Development. 2012 ; Vol. 26, No. 24. pp. 2673-2683.
@article{16d8624fba804302be487f06a2dde118,
title = "BAF60 A, B, and Cs of muscle determination and renewal",
abstract = "Developmental biologists have defined many of the diffusible and transcription factors that control muscle differentiation, yet we still have only rudimentary knowledge of the mechanisms that dictate whether a myogenic progenitor cell forms muscle versus alternate lineages, including those that can be pathological in a state of disease or degeneration. Clues about the molecular basis for lineage determination in muscle progenitors are only now emerging from studies of chromatin modifications that avail myogenic genes for transcription, together with analysis of the composition and activities of the chromatin-modifying complexes themselves. Here we review recent progress on muscle determination and explore a unifying theme that environmental cues from the stem or progenitor niche control the selection of specific subunit variants of the switch/sucrose nonfermentable (SWI/SNF) chromatin-modifying complex, creating a combinatorial code that dictates whether cells adopt myogenic versus nonmyogenic cell fates. A key component of the code appears to be the mutually exclusive usage of the a, b, and c variants of the 60-kD structural subunit BAF60 (BRG1/BRM-associated factor 60), of which BAF60c is essential to activate both skeletal and cardiac muscle programs. Since chromatin remodeling governs myogenic fate, the combinatorial assembly of the SWI/SNF complex might be targeted to develop drugs aimed at the therapeutic reduction of compensatory fibrosis and fatty deposition in chronic muscular disorders.",
keywords = "Cardiomyocyte, Fibrosis, Satellite cell, Smarcd3, TGF β",
author = "Puri, {Pier Lorenzo} and Mark Mercola",
year = "2012",
doi = "10.1101/gad.207415.112",
language = "English",
volume = "26",
pages = "2673--2683",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "24",

}

TY - JOUR

T1 - BAF60 A, B, and Cs of muscle determination and renewal

AU - Puri, Pier Lorenzo

AU - Mercola, Mark

PY - 2012

Y1 - 2012

N2 - Developmental biologists have defined many of the diffusible and transcription factors that control muscle differentiation, yet we still have only rudimentary knowledge of the mechanisms that dictate whether a myogenic progenitor cell forms muscle versus alternate lineages, including those that can be pathological in a state of disease or degeneration. Clues about the molecular basis for lineage determination in muscle progenitors are only now emerging from studies of chromatin modifications that avail myogenic genes for transcription, together with analysis of the composition and activities of the chromatin-modifying complexes themselves. Here we review recent progress on muscle determination and explore a unifying theme that environmental cues from the stem or progenitor niche control the selection of specific subunit variants of the switch/sucrose nonfermentable (SWI/SNF) chromatin-modifying complex, creating a combinatorial code that dictates whether cells adopt myogenic versus nonmyogenic cell fates. A key component of the code appears to be the mutually exclusive usage of the a, b, and c variants of the 60-kD structural subunit BAF60 (BRG1/BRM-associated factor 60), of which BAF60c is essential to activate both skeletal and cardiac muscle programs. Since chromatin remodeling governs myogenic fate, the combinatorial assembly of the SWI/SNF complex might be targeted to develop drugs aimed at the therapeutic reduction of compensatory fibrosis and fatty deposition in chronic muscular disorders.

AB - Developmental biologists have defined many of the diffusible and transcription factors that control muscle differentiation, yet we still have only rudimentary knowledge of the mechanisms that dictate whether a myogenic progenitor cell forms muscle versus alternate lineages, including those that can be pathological in a state of disease or degeneration. Clues about the molecular basis for lineage determination in muscle progenitors are only now emerging from studies of chromatin modifications that avail myogenic genes for transcription, together with analysis of the composition and activities of the chromatin-modifying complexes themselves. Here we review recent progress on muscle determination and explore a unifying theme that environmental cues from the stem or progenitor niche control the selection of specific subunit variants of the switch/sucrose nonfermentable (SWI/SNF) chromatin-modifying complex, creating a combinatorial code that dictates whether cells adopt myogenic versus nonmyogenic cell fates. A key component of the code appears to be the mutually exclusive usage of the a, b, and c variants of the 60-kD structural subunit BAF60 (BRG1/BRM-associated factor 60), of which BAF60c is essential to activate both skeletal and cardiac muscle programs. Since chromatin remodeling governs myogenic fate, the combinatorial assembly of the SWI/SNF complex might be targeted to develop drugs aimed at the therapeutic reduction of compensatory fibrosis and fatty deposition in chronic muscular disorders.

KW - Cardiomyocyte

KW - Fibrosis

KW - Satellite cell

KW - Smarcd3

KW - TGF β

UR - http://www.scopus.com/inward/record.url?scp=84871590663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871590663&partnerID=8YFLogxK

U2 - 10.1101/gad.207415.112

DO - 10.1101/gad.207415.112

M3 - Article

C2 - 23222103

AN - SCOPUS:84871590663

VL - 26

SP - 2673

EP - 2683

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 24

ER -